Infinity Pharmaceuticals Inc. (INFI): Watch This Data

Page 1 of 8

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds’ portfolio at the end of December. INFI has experienced an increase in enthusiasm from smart money of late. There were 16 hedge funds in our database with INFI holdings at the end of the previous quarter.

In the 21st century investor’s toolkit, there are plenty of methods market participants can use to monitor publicly traded companies. Two of the most useful are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the elite hedge fund managers can trounce their index-focused peers by a superb margin (see just how much).

Equally as important, positive insider trading sentiment is another way to break down the marketplace. There are lots of stimuli for a bullish insider to cut shares of his or her company, but only one, very simple reason why they would behave bullishly. Plenty of academic studies have demonstrated the valuable potential of this tactic if piggybackers understand what to do (learn more here).

With all of this in mind, let’s take a peek at the recent action regarding Infinity Pharmaceuticals Inc. (NASDAQ:INFI).

How have hedgies been trading Infinity Pharmaceuticals Inc. (NASDAQ:INFI)?

In preparation for this year, a total of 22 of the hedge funds we track were long in this stock, a change of 38% from the third quarter. With hedgies’ sentiment swirling, there exists a select group of noteworthy hedge fund managers who were increasing their stakes considerably.

Of the funds we track, Samuel Isaly’s OrbiMed Advisors had the most valuable position in Infinity Pharmaceuticals Inc. (NASDAQ:INFI), worth close to $111.3 million, comprising 3.4% of its total 13F portfolio. On OrbiMed Advisors’s heels is Perceptive Advisors, managed by Joseph Edelman, which held a $89.1 million position; 15.7% of its 13F portfolio is allocated to the stock. Some other peers with similar optimism include Daniel Gold’s QVT Financial, Julian Baker and Felix Baker’s Baker Bros. Advisors and Sean Cullinan’s Point State Capital.

Now, specific money managers were breaking ground themselves. Deerfield Management, managed by James E. Flynn, created the largest position in Infinity Pharmaceuticals Inc. (NASDAQ:INFI). Deerfield Management had 20.1 million invested in the company at the end of the quarter. Donald Chiboucis’s Columbus Circle Investors also initiated a $8.7 million position during the quarter. The other funds with brand new INFI positions are SAC Subsidiary’s Sigma Capital Management, Samuel Isaly’s OrbiMed Advisors, and Mark Broach’s Manatuck Hill Partners.

Insider trading activity in Infinity Pharmaceuticals Inc. (NASDAQ:INFI)

Insider buying is at its handiest when the company in question has seen transactions within the past six months. Over the last six-month time frame, Infinity Pharmaceuticals Inc. (NASDAQ:INFI) has seen zero unique insiders purchasing, and 2 insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Infinity Pharmaceuticals Inc. (NASDAQ:INFI). These stocks are Incyte Corporation (NASDAQ:INCY), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Questcor Pharmaceuticals Inc (NASDAQ:QCOR), Charles River Laboratories (NYSE:CRL), and Theravance Inc (NASDAQ:THRX). All of these stocks are in the biotechnology industry and their market caps are similar to INFI’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Incyte Corporation (NASDAQ:INCY) 15 1 6
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) 11 0 1
Questcor Pharmaceuticals Inc (NASDAQ:QCOR) 21 2 2
Charles River Laboratories (NYSE:CRL) 20 0 7
Theravance Inc (NASDAQ:THRX) 10 1 1

With the results exhibited by Insider Monkey’s studies, retail investors must always monitor hedge fund and insider trading sentiment, and Infinity Pharmaceuticals Inc. (NASDAQ:INFI) shareholders fit into this picture quite nicely.

See the 7 most bullish money managers:

Page 1 of 8
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Top 10 Highest Paying Jobs in the World

Most Expensive Day-Care in New York City

The 10 Cheapest Places to Retire Abroad

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!